No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

A new experimental vaccine developed by researchers at MIT and Caltech could offer protection against emerging variants of SARS-CoV-2, as well as related coronaviruses, known as sarbecoviruses, that ...

President Donald Trump announced a $500billion investment for private companies to develop artificial intelligence tools to ...

Legislation that would block hospitals from transfusing blood containing COVID-19 antibodies or “synthetic mRNA” could have ...

We rate BioNTech SE a hold due to volatile performance, weak growth, and premium valuation amidst COVID-19 vaccine reliance.

Not long after the Illinois Department of Health announced the state’s overall respiratory illness cases had reached the ...

Public health experts say there could be massive implications after President Trump signed an executive order withdrawing the U.S. from the World Health Organization.

The mRNA-1273.815 vaccine provided significant protection against COVID-19-related hospitalizations and medically attended COVID-19 among US adults.

The president announced a major AI investment project, which Oracle Chairman Larry Ellison said could be used to cure cancer.

As Moderna (NASDAQ: MRNA) looks to shore up its business in the wake of its declining coronavirus vaccine sales, it's natural for investors to wonder about where the biotech will go in the near future ...

Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight bird flu.